SCHEMBL6527935

SCHEMBL6527935

COC(=O)[C@@H](CC(C)C)Nc1nc(Nc2cccc(F)c2)nc(Sc2ncccn2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ NPR3 P17342 6/20 0.40
▸ TAS1R3 Q7RTX0 1/20 0.39
▸ TAS1R1 Q7RTX1 1/20 0.39
▸ SYK P43405 3/20 0.39
▸ CYP2C9 P11712 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C8 P10632 1/20 0.39
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CDC7 O00311 1/20 0.37
▸ DAPK3 O43293 1/20 0.37
▸ PRKD3 O94806 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6527923 1.00 MAPK1 (0.41) MAPK1HTTNPR3TAS1R3TAS1R1
SCHEMBL6508189 0.87 KCNH3 (0.41) MAPK1HTTNPR3TAS1R3TAS1R1
SCHEMBL6508192 0.87 KCNH3 (0.41) MAPK1HTTNPR3TAS1R3TAS1R1
SCHEMBL6530463 0.85 NPR3 (0.55) NPR3CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL6530469 0.85 NPR3 (0.55) NPR3CYP2C9CYP2C19CYP1A2CYP3A4
SCHEMBL6529452 0.80 CDC7 (0.44) NPR3SYKCYP2C9CYP2C19CYP1A2
SCHEMBL6530078 0.80 RORC (0.45) CYP2C9CYP2C19CYP1A2KCNH3
SCHEMBL6529455 0.80 CDC7 (0.44) NPR3SYKCYP2C9CYP2C19CYP1A2
SCHEMBL6530084 0.80 RORC (0.45) CYP2C9CYP2C19CYP1A2KCNH3
SCHEMBL6528847 0.80 SYK (0.43) SYKCYP2C9CYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 — — WO claimed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 — — WO disclosed
Send feedback